纠正:病例系列:四名转移性黄染色细胞瘤患者的ATRX变异
Briana N Cortez1, Mickey J M Kuo1,2, Abhishek Jha1
1Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, United States.
Frontiers in endocrinology
|December 1, 2025
概括
这项研究对先前发表的文章进行了纠正,确保了科学记录的准确性. 它强调了精确数据对于推进内分泌研究的重要性.
科学领域:
- 内分泌学 在内分泌学.
- 医学研究 医学研究
背景情况:
- 确保发表的科学文献的准确性对于可靠的研究至关重要.
- 纠正是保持科学记录完整性和防止错误信息所必需的.
研究的目的:
- 在以前发表的文章中正式纠正错误.
- 为了提供准确的文章DOI,以便适当引用和检索.
主要方法:
- 发出了一份正式的纠正通知.
- 错误的DOI被确定并用正确的DOI取代.
主要成果:
- 这篇文章的DOI已被纠正为10.3389/fendo.2024.1399847.
- 这样可以确保读者和数据库能够访问正确的研究版本.
结论:
- 校正维护了科学记录的完整性.
- 准确的DOI对于科学发现的可复制性和可追溯性至关重要.
相关概念视频
Adrenal Gland Disorders
2.8K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
2.8K
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
1.3K
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
1.3K
Adrenergic Receptors: ɑ Subtype
2.6K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
2.6K


